Cargando…
Treatment patterns of targeted and nontargeted therapies and survival effects in patients with locally advanced head and neck cancer in Taiwan
BACKGROUND: Taiwan’s National Health Insurance has covered targeted therapy, namely cetuximab, for locally advanced head and neck cancers (LAHNC) since July 2009. This study examines treatment trends and survival effects of locally advanced head and neck cancer patients before and after Taiwan’s Nat...
Autores principales: | Hu, Szu-Han, Huang, Ming-Yii, Chen, Chung-Yu, Hsieh, Hui-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10283176/ https://www.ncbi.nlm.nih.gov/pubmed/37340424 http://dx.doi.org/10.1186/s12885-023-11061-4 |
Ejemplares similares
-
Management of Older Adults with Locally Advanced Head and Neck Cancer
por: Dickstein, Daniel R., et al.
Publicado: (2022) -
L-Glutamine and Survival of Patients with Locally Advanced Head and Neck Cancer Receiving Chemoradiotherapy
por: Tsujimoto, Takae, et al.
Publicado: (2023) -
Local hyperthermia in head and neck cancer: mechanism, application and advance
por: Gao, Shiyu, et al.
Publicado: (2016) -
Curative-Intent Aggressive Treatment Improves Survival in Elderly Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma and High Comorbidity Index
por: Chen, Jin-Hua, et al.
Publicado: (2016) -
Evaluation of survival of patients with locally advanced head and neck cancer treated in a single center
por: Santos, Fred Muller dos, et al.
Publicado: (2019)